FindTrial
Sign In

Study on patients undergoing liver surgery to check how well the liver is working before surgery and to predict chances of liver problems after surgery and also to devolep a pictorial chart which will help in predication of liver failure.

Preoperative risk assessment for post-hepatectomy liver failure (PHLF) by FLR, ICG and indocycanine green and development of a model predicting PHLF using all three modalities. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/09/094078
Enrollment
100
Registered
2025-09-01
Start date
Unknown
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C228- Malignant neoplasm of liver, primary, unspecified as to type Health Condition 2: O- Medical and Surgical

Interventions

Intervention1: Nil: Nil Control Intervention1: NIL: NIL

Sponsors

Tata Memorial Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.All patients over 18 years of age, planned for major hepatectomies 2.Patient planned for minor hepatectomies, but ICG and Fibroscan deemed necessary after multi-disciplinary discussion in view of cirrhosis.

Exclusion criteria

Exclusion criteria: 1. Minor Hepatectomies (except the above) 2.Patient who refused to give valid consent for the study 3.Patients who are unfit for surgery due to medical comorbidities 4.Patients with Obstructive Jaundice (ICG clearance impaired)

Design outcomes

Primary

MeasureTime frame
To investigate the effectiveness of combination of FLR, ALBI score, APRI score, ICG and Fibroscan in predicting incidence of PHLF, Severity of PHLF and peri-operative mortality in Posthepatectomy liver failure Timepoint: till hospital stay after surgery and day 30, day 60 post surgery—

Secondary

MeasureTime frame
Risk of Hepatic decompensation laterTimepoint: beyond 3 months after surgery;disease Recurrences, Overall survival, and Disease free survival after hepatectomy Timepoint: day 30, day 60 and then every 6 monthly;To develop a predictive model for PHLF using the modalities.Timepoint: day 30, day 60 and then every 6 monthly—

Countries

India

Contacts

Public ContactDR TAHER ALI KOTWALA

Tata Memorial Hospital

drmaheshgoel@gmail.com9820504492

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026